Catatonia in Nodding Syndrome and Lorazepam Treatment
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Nodding Syndrome is an enigmatic neuropsychiatric syndrome affecting children and adolescents
mostly in Eastern Africa. The symptoms of Nodding Syndrome and catatonia seem to overlap. The
researchers' objectives in this study were to investigate the presence and types of catatonic
symptoms in children with Nodding Syndrome and observe their response to one or two doses of
lorazepam, the first-line treatment for catatonia.